Novo Nordisk’s IL-6 inhibitor ziltivekimab failed to reduce the risk of cardiovascular events in the late-stage trial, dashing hopes for an edge in the hyper-competitive cardiometabolic space.
Novo’s IL-6 inhibitor fails in cardiovascular Phase 3, plunging shares more than 9% Read More »
AbbVie investors’ sky-high expectations led to a 4% share decline on Friday as the company reported more modest consensus beats than expected.
AbbVie shares pressured as Q2 I&I beat falls below investor expectations Read More »
CEO Kevin Lobo said the company is working through a backlog of orders and grappling with a supply disruption related to Inari Medical.
Stryker catching up on orders, manufacturing after cyberattack Read More »
The deal to provide a range of imaging and therapeutic technologies to Cleveland Clinic extends the partners’ longtime relationship and follows a recent 10-year pact between Siemens Healthineers and Mayo Clinic.
Siemens Healthineers, Cleveland Clinic form 10-year alliance Read More »
The deal to provide a range of imaging and therapeutic technologies to Cleveland Clinic extends the partners’ longtime relationship and follows a recent 10-year pact between Siemens Healthineers and Mayo Clinic.
Siemens Healthineers, Cleveland Clinic form 10-year alliance Read More »
UniQure is ready to put its Huntington’s disease gene therapy through an advisory committee meeting—even as the broader rare disease space has been put on edge by recent FDA scrutiny of assets by Replimune and Capricor.
Alnylam’s revenue cut “may create a near term credibility overhang and could “raise questions on peak sales potential, even if there’s tailwinds in the competitive landscape,” according to Stifel.
Alnylam absorbs $10.8B blowback after cutting full-year guidance for TTR franchise Read More »
Durante años, la ciberseguridad se basó principalmente en detectar amenazas conocidas y reaccionar cuando un ataque ya estaba en curso. Sin embargo, el escenario actual es mucho más complejo: los ciberdelincuentes utilizan técnicas más avanzadas, automati …
El papel de la Inteligencia Artificial en la detección proactiva de amenazas digitales Read More »
¿Qué ocurre exactamente cuando dos moléculas chocan para formar una nueva sustancia? Durante generaciones, la química se pareció mucho a la macroeconomía: sabíamos qué ingredientes poníamos al principio y qué productos obten&iacut …
El laboratorio de la empresa biotecnológica Colossal Biosciences en Texas no duerme. Entre secuenciadores de ADN de última generación y CRISPR, las tijeras de edición genética más famosas del mundo, un equipo de científicos trabaja con una meta que pa …
